Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pridopidine vs placebo for safety and effectiveness in levodopa-induced dyskinesia in Parkinson's disease; study terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pridopidine (pridopidine)

Snippet

Sponsor: Prilenia | Conditions: Parkinson Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-07-01